A
BMY icon

AlphaQuest’s Bristol-Myers Squibb BMY Stock Holding History

AlphaQuest’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,321
Closed -$719K – 287
2025
Q4 		$719K Buy
13,321
+2,004
+18% +$96.4K 0.04% 595
2025
Q3 		$510K Sell
11,317
-7,627
-40% -$356K 0.03% 781
2025
Q2 		$877K Buy
18,944
+14,325
+310% +$703K 0.09% 348
2025
Q1 		$282K Sell
4,619
-14,132
-75% -$824K 0.03% 809
2024
Q4 		$1.06M Buy
18,751
+6,595
+54% +$368K 0.14% 222
2024
Q3 		$629K Sell
12,156
-28,722
-70% -$1.35M 0.06% 563
2024
Q2 		$1.7M Buy
40,878
+40,742
+29,957% +$1.82M 0.23% 122
2024
Q1 		$7.38K Sell
136
-18,602
-99% -$948K ﹤0.01% 1088
2023
Q4 		$961K Buy
+18,738
New +$984K 0.2% 155

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AlphaQuest's BMY Position: Q1 2026 in Review

AlphaQuest sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 13,321 shares — an estimated $719K sold.

AlphaQuest first reported a position in BMY in Q4 2023 and held it in 9 quarters. The position peaked at $1.7M in Q2 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • AlphaQuest reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 13,321 Bristol-Myers Squibb shares in Q1 2026, an estimated $719K.
  • AlphaQuest first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Bristol-Myers Squibb position peaked at $1.7M in Q2 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.